Abstract
INTRODUCTION Global medical advances within
healthcare have subsequently led to the widespread introduction of
biological products such as grafts, haemostats, and sealants. Although
these products have been used for many decades, this subject is
frequently not discussed during the consent process and remains an area
of contention.